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Glycosylated cyclophellitol-derived activity-based
probes and inhibitors for cellulases†
Casper de Boer, ‡a Nicholas G. S. McGregor,‡b Evert Peterse,a
Sybrin P. Schro¨der,a Bogdan I. Florea,a Jianbing Jiang,a Jos Reijngoud,c
Arthur F. J. Ram,c Gilles P. van Wezel, c Gijsbert A. van der Marel,a
Jeroen D. C. Code´e, a Herman S. Overkleeft *a and Gideon J. Davies *b
Cellulases and related b-1,4-glucanases are essential components of lignocellulose-degrading enzyme
mixtures. The detection of b-1,4-glucanase activity typically relies on monitoring the breakdown of
purified lignocellulose-derived substrates or synthetic chromogenic substrates, limiting the activities which
can be detected and complicating the tracing of activity back to specific components within complex
enzyme mixtures. As a tool for the rapid detection and identification of b-1,4-glucanases, a series of
glycosylated cyclophellitol inhibitors mimicking b-1,4-glucan oligosaccharides have been synthesised.
These compounds are highly efficient inhibitors of HiCel7B, a well-known GH7 endo-b-1,4-glucanase. An
elaborated activity-based probe facilitated the direct detection and identification of b-1,4-glucanases
within a complex fungal secretome without any detectable cross-reactivity with b-D-glucosidases. These
probes and inhibitors add valuable new capacity to the growing toolbox of cyclophellitol-derived probes
for the activity-based profiling of biomass-degrading enzymes.
Introduction
Activity-based protein profiling (ABPP) is a powerful technique
used to detect and identify active enzymes using modified
covalent inhibitors. Following early successes in the detection
and identification of proteases,1 this technique has been
extended to glycoside hydrolases using a variety of strategies,2,3
including labelled cyclophellitol derivatives.4
Though often considered synonymous with cellulases, b-1,4-
glucanases are enzymes which recognize b-1,4-linked glucan
chains which are characteristic of both the cellulosic and
hemicellulosic (i.e. mixed-linkage glucans, xyloglucans, and
glucomannans) fractions of plant biomass.5 The catalytic
actions of a variety of retaining b-1,4-glucanases contribute
to the breakdown of lignocellulosic polysaccharides.6,7 The
efficient and specific profiling of b-1,4-glucanases is thus a
valuable tool in the study of biomass-degrading organisms.
Efforts have been made to profile b-1,4-glycanases using
different ‘‘warhead’’ chemistries. Activity-based probes (ABPs)
based on a 2,4-dinitrophenyl 2-deoxy-2-fluoro-b-xylobioside/
cellobioside modified with an affinity tag at the 4’ position
proved effective probes for retaining b-D-glucanases and
b-xylanases with particularly good specificity.2,8,9 However, the
slow hydrolysis of the enzyme-probe complex and the weak
initial binding of these probes necessitated the use of high
probe concentration (B0.5–1 mM) and time-limited labelling
for ABPP. Later experiments using difluoromethylphenyl glyco-
sides and N-haloacetyl glycosylamines demonstrated a unique
capacity to label inverting glycoside hydrolases, but suffered
from significant non-specific labelling.3
Cyclophellitol is an inhibitor of b-D-glucosidases originally iso-
lated from the Phellinusmushroom.10 This cyclitol is an isostere of a
glucoside where the acetal group is replaced by an epoxide. Taking
advantage of the catalytic machinery of a retaining glycoside hydro-
lase, this epoxide undergoes an acid-catalysed ring opening addition
to form a non-hydrolysable ester in place of the normal glycosyl-
enzyme intermediate, irreversibly inactivating the enzyme.11
ABPs built around synthetic cyclitols, having configurations
which target a- and b-D-glucosidases,12–14 b-D-glucuronidases,15
b-D-xylosidases,16 a- and b-D-galactosidases,17,18 and a-L-arabino-
furanosidases,19 among others, have consistently been shown to
covalently modify the catalytic nucleophiles of cognate retaining
glycosidases. These cyclophellitol-derived ABPs generally bind
with good specificity, high affinity, and complete irreversibility.
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Recent work has shown that cyclophellitol derivatives can
be glycosylated, enabling the development of inhibitors and
probes which react specifically with endo-glycanases.16 This was
first demonstrated with the development of an inhibitor and a
collection of ABPs for b-1,4-xylanases. Being built around a
xylobiose core with an alkylated aziridine warhead, these
probes proved to be potent covalent inhibitors of GH10 b-1,4-
xylanases, but showed cross-reactivity with b-D-xylosidases
when applied to the direct detection of b-xylanases within
fungal secretomes. This cross-reactivity was traced back to the
internal hydrolysis of the probe by the action of b-D-xylosidases.
Building on this understanding, here we report the develop-
ment of cyclophellitol-derived ABPs designed to target b-1,4-
glucanases, some of the most abundant glycoside hydrolases
in nature. To detect and profile these enzymes, a collection of
4-O substituted (carbohydrate numbering) cyclophellitols have
been synthesised and tested for their ability to covalently modify
HiCel7B, a well-known endo-b-1,4-glucanase. Through bio-
chemical, structural, and mass spectrometric analyses, we have
identified a potent substrate-mimicking probe architecture
which shows resistance to hydrolysis by exo-glucosidase and
endo-glucanase activities within a fungal secretome.
Experimental
Synthesis of b-D-glucanase inhibitors and probe
Chemical synthesis details and compound analysis is reported
in the ESI.†
Testing b-D-glucanase inhibitors and probes
HiCel7B was a kind gift from Martin Schu¨lein (sadly now
deceased) at Novozymes A/S (Lyngby, Denmark). The pH-activity
profile of HiCel7B acting on 4-methylumbelliferyl b-D-cellobioside
(4MU-GG) was measured by combining 5 mL of 1 mg mL1
HiCel7B in 200 mM 2 :7 : 7 succinate–phosphate–glycine (SPG)
buffer prepared at various pH values with 45 mL of 0.1 mM
substrate in quadruplicate. The reactions were incubated at
25 1C for 30 minutes prior to the addition of 5 mL of 1 M Na2CO3,
transfer of 50 mL to a black 384-well plate and fluorescence
measurement (lex = 360 nm, lem = 450 nm). Rates were
determined using a 4-methylumbelliferone calibration series
prepared in 0.1 M Na2CO3.
Intact MS of HiCel7B bound to different inhibitors was
performed according to McGregor et al.19 Briefly, enzyme was
diluted to 0.1 mg mL1 (B2.2 mM) in 20 mM sodium phosphate
buffer pH 7. Compounds 1, 5, or 13 were added to a final
concentration of 5 mM and incubated at 25 1C. Samples taken at
1 hour were diluted with 4 volumes of 1% formic acid, 10%
acetonitrile and analysed. Additional experiments with 5 were
performed using different concentrations of inhibitor and
enzyme as indicated in the text.
Inhibition kinetics for compounds 1, 5, and 13 acting on
HiCel7B were measured at 25 1C using 4MU-GG following a
method described previously.19 Briefly, enzyme was diluted in
50 mM sodium phosphate buffer pH 7. Substrate was dissolved
in DMSO to give a 10 mM stock which was diluted with ultrapure
water. Inhibitors were dissolved in and diluted with ultrapure
water with the exception of 13 which was dissolved in DMSO to
give a 5 mM stock which was diluted with ultrapure water. The
enzyme and substrate concentrations used in the continuous
inhibition assays were 10 ng mL1 (B220 pM) and 50 mM,
respectively. The KM value for the interaction of HiCel7B with
4MU-GG under the assay conditions (corrected for inner filter
effect) was measured to be 76 mM (Fig. S1, ESI†) and this was used
as a correction factor to determine the KI values in Table 1 from the
apparent KI determined from fitting of kapp vs. [inhibitor] curves.
Enzyme crystallisation, diffraction, and structure solution
Deglycosylated HiCel7B was desalted into 20 mM pH 8 Tris–HCl
buffer and concentrated to 12 mg mL1 using a 30 kDa MWCO
centricon. Building on previous reports,20,21 crystallisation
conditions were re-screened using the PACT Suite and AmSO4
Suite (Qiagen) crystallisation screens. High quality tetragonal
bipyramidal crystals grew consistently at 20 1C from a 2 : 1
mixture of protein solution:well solution, where well solution
was 0.15 M sodium citrate, 0.8 M ammonium sulfate, 1 M
lithium sulfate (Fig. S2, ESI†). Crystal soaks were performed in
a solution composed of 0.1 mM ligand in mother liquor for
5 hours at 20 1C prior to transfer into mother liquor supple-
mented with 20% glycerol and cryo-cooling in LN2.
Crystals were diffracted at Diamond Light Source (Harwell, UK)
on beamline I03 at a wavelength of 0.9762 Å and automatically
processed using the Xia222 pipeline with 3dii. Computation was
carried out using programs from the CCP4 suite23 unless other-
wise stated. All crystal structure figures were generated using
Pymol (Schrodinger). Data collection and processing statistics
for all structures are given in Table S1 (ESI†).
Data for HiCel7B bound to compound 1 were collected to
1.88 Å. Data were also collected out to 1.2 Å in a higher space
group (P42212) following a soak with 13, though the structure
was found to be unliganded. The structure of 1-bound HiCel7B
was solved in the P4122 space group by molecular replacement
using Phaser24 with the known structure (PDBID: 2A39) as the
search model. Ligand 1 was built using the existing restrains for
b-D-glucose (BGC) and cyclophellitol (YLL) with Coot,25 and
structures were refined by alternating rounds of manual model
building and density refinement using Coot and REFMAC526
respectively.
In-gel fluorescence
The pH-labelling profile of HiCel7B reacting with the probe was
measured by combining 10 mL of 1 mg mL1HiCel7B in 200 mM
Table 1 Kinetic parameters for covalent inhibition of HiCel7B by putative
b-1,4-glucanase inhibitors
Compound
HiCel7B
KI (mM) kinact (min
1) kinact/KI (s
1 M1)
1 31  4 0.84  0.08 450
5 1.9  0.3 0.35  0.03 3100
13 3.9  0.3 0.50  0.03 2100
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SPG buffer prepared at various pH values with 10 mL of 10 mM
14 in quadruplicate. The reactions were incubated at 25 1C for
10 minutes prior to the addition of 8 mL of 4 SDS-PAGE loading
dye and heating to 95 1C for 2 minutes. 10 mL of each reaction
was separated on a 10% SDS-PAGE gel prior imaging using the
Cy5 laser/filter settings on a Typhoon 5 scanner (GE Healthcare).
Bands were integrated using ImageQuant (GE Healthcare).
Secretome staining was performed using two aliquots of
20 mL xylan-grown Aspergillus niger secretome (day 4 samples
prepared as described previously16). To each was added 5 mL of
0.5 M pH 5 McIlvane buffer. To one was then added 5 mL of
60 mM 14 and to the other was added 5 mL of 60 mM 19 (10 mM
final ABP concentration). These were incubated for 30 minutes
at 37 1C. The reactions were then split in two and one half
(15 mL) was diluted with 5 mL of water. The other half (15 mL) of
the reaction with 19 was then supplemented with 5 mL of 40 mM
14 and the other half of the reaction with 14 was supplemented
with 5 mL of 40 mM 19 (10 mM final ABP concentration). The
reactions were incubated for a further 30 minutes at 37 1C
before being diluted with 8 mL of 4 SDS-PAGE loading dye,
separated on a 4–20% SDS-PAGE gel (Bio-Rad) and imaged for
fluorescence using the Cy2 and Cy5 laser/filter settings on a
Typhoon 5 scanner (GE Healthcare).
Biotin–avidin enrichment proteomic analysis
5 aliquots of 1 mL of xylan-grown Aspergillus niger secretome
were thawed from 80 1C, centrifuged at 12 000  g for
15 minutes to remove particulate and combined. 0.5 mL of
this was then subsampled into 9 separate Lo-Bind 2.0 mL tubes.
To three tubes was added 55 mL of 1 mM compound 1 in
ultrapure water, and to the rest 55 mL of ultrapure water. All
samples were incubated for 1 hour at 37 1C prior to the addition
of 60 mL of compound 15 in 10% DMSO to the samples treated
with 1 and three of the samples not treated with 1. 10% DMSO
was added to the remaining three samples. All of the samples
were incubated for a further 2 hours at 37 1C. Proteins were
denatured by heating to 95 1C for 5 minutes following the
addition of 70 mL of 10 denaturing buffer (500 mMNa-HEPES,
pH 7.5, 50 mM DTT, 5% SDS). Once cooled to RT, thiols were
alkylated by the addition of 70 mL of 0.25 M iodoacetamide and
incubation in the dark for 30 minutes. Samples were trans-
ferred to 5 mL Eppendorf tubes and proteins were precipitated
by the addition of 3.2 mL of chilled acetone followed by
incubation at 20 1C for 1 hour. Proteins were collected by
centrifugation (14 000  g for 1 minute) and the supernatant
was discarded. The pellet was washed with 3 mL of cold acetone
and air-dried. The pellet was then resuspended in 50 mL of 8 M
urea, 10 mM HEPES, pH 7.2 and diluted with 150 mL of 0.05%
SDS in phosphate-buffered saline (PBS). This was shaken over-
night at 20 1C to dissolve. The samples were then diluted with a
further 200 mL of 0.05% SDS in PBS and centrifuged to collect
any insoluble residue. The supernatant was transferred to a
2 mL Eppendorf tube and mixed with 25 mL of Pierce Avidin
Agarose beads (Thermo Fisher Scientific) which had been
washed twice with PBS. Following 3 hours of mixing by inver-
sion, beads were collected by centrifugation for 2 minutes at
2500  g. The supernatant was removed and the beads were
washed with 500 mL of 0.5% SDS in PBS once, 500 mL of 2% SDS
at 65 1C for 10 minutes once, 500 mL of 0.5% SDS in PBS again,
then 500 mL of 2 M urea followed by two washes with 500 mL of
ultrapure water. The beads were finally resuspended in 20 mL of
on-bead digestion buffer and trypsinisation, StageTip desalting,
LC-MS/MS data acquisition, and data processing were performed
as described previously.27 Peptides were identified by searching
against a database of A. niger NRRL3 proteins28 supplemented
with streptavidin, avidin, yeast enolase and trypsin. The combined
search results were filtered for a minimum of two unique peptides
with a false-discovery rate of 4%. Label-free quantification was
performed using Progenesis QI (Waters). Following chromato-
graphic alignment, peaks were integrated and assigned. Protein
abundance was estimated using the integrated intensity of non-
conflicting peptides. Results of this analysis for all identified
proteins can be found in Table S2 (ESI†).
Results and discussion
Synthesis of potential cellulase inhibitors and probes
Cellobiose configured cyclophellitol (1) was synthesized via
previously reported procedures.16 Glycosylation of cyclophellitol
acceptor 2 with cellobiose-derived N-phenyl trifluoroacetimidate
3 afforded pseudo-trisaccharide 4 (Scheme 1). The deprotection
sequence: benzoyl removal by NaOMe in MeOH, followed by
short hydrogenation over a high loading of Pearlman’s catalyst,29
yielded inhibitor 5.
To gain access to cellobiose configured ABPs 4-deoxy-4-azido-
thioglucoside donor 9 was synthesized. Themethods are similar to
a published synthesis of 4-deoxy-4-fluoro-thioglucoside donors.30
The axial 4-OH of partially protected methyl a-D-galactopyranoside
6 was activated as a triflate and substituted by sodium azide
leading to 7. Acid-catalyzed displacement of the anomeric methoxy
group afforded anomeric acetate 8. Introduction of the anomeric
thiophenol yielded donor 9.
The glycosylation reaction was improved, compared to
that employed in the inhibitor synthesis. Application of a pre-
activation protocol (Tf2O/Ph2SO) circumvents the use of
relatively high temperatures and long reaction times required
to activate this type of donor using NIS/TfOH. It also allows the
activation of the donor to take place without the presence of the
acid-labile epoxide. Disaccharide 10 was obtained in 64% yield
without the use of a large excess of donor. Unreacted acceptor
(2) was also recovered indicating the stability of the epoxide
functionality under these conditions. Increasing the amount of
donor (9) led to diminished yield and complex mixtures. This
was presumably due to the reaction of the epoxide in the
product with the excess activated donor.31
Following the synthesis of disaccharide 10, the benzoyl esters
were removed with NaOMe affording 11. Staudinger reduction of
the azide followed by benzyl removal under Birch conditions
afforded fully deprotected 12.
Azide-terminated triethylene glycol t-butyl ester 1632 was
deprotected using trifluoroactic acid and DIC/DMAP mediated
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esterification with pentafluorophenol afforded activated
ester 17. The amine in 12 was selectively acylated with 17,
yielding probe 13 following semi-preparative HPLC purifica-
tion. Cy5-labeled probe 14 was obtained after copper catalyzed
click reaction of 13 with Cy5 alkyne. Biotin-labeled probe 15
was synthesized in one step from 12 by amide bond forma-
tion with biotin-terminated spacer 18, obtained from 16 in
3 steps.
BODIPY green-labeled b-glucosidase probe 19 was obtained
by methods developed for the previously reported BODIPY red
variant using BODIPY green alkyne.33,34
Testing potential cellulase inhibitors and probes with HiCel7B
Humicola insolens Cel7B (HiCel7B) was chosen as a model
b-D-glucanase since it is well-characterized, has good hydrolytic
performance with chromogenic substrates, can be readily
crystallised, and has been studied in our lab previously.20,21,35
Compound 1 proved to be an efficient covalent inhibitor of
HiCel7B, with a ki/KI of 450 M
1 s1 (Fig. 1 and Table 1). Intact
MS confirmed complete, single labelling after 60 minutes at
25 1C (Fig. 2A). These kinetics compare favourably with the
reported requirement to incubate F. oxysporum EG I with
8.25 mmol of 3,4-epoxybutyl b-D-cellobioside for 3 hours at
40 1C to achieve complete inhibition.36
The addition of another b-1,4-linked glucose residue to the
non-reducing terminus to give 5 improved the performance of
the inhibitor roughly 7-fold (Table 1 and Fig. S3, ESI†), however
intact MS with 2.2 mM enzyme and 5 mM inhibitor revealed
minimal labelling (Fig. S4, ESI†). Treatment with 5 gave small
peaks with mass differences of both B338 Da (equivalent to
addition of 1) andB500 Da (expected). Soaking HiCel7B crystals
with 0.1 mM 5 also gave an unliganded enzyme structure.
Repeating the intact MS experiment with a higher inhibitor
concentration (50 mM) resulted in more overall labelling, but
still a dominant mass difference of B338 Da. Lowering the
inhibitor (5 mM) and enzyme concentrations (0.5 mM) gave
overall weaker signal, showing incomplete labelling, with a
mass difference attributable to 5 as the dominant modification
(Fig. S4, ESI†). We interpret these results as indicative of an
internal hydrolysis of 5 to give primarily a mixture of cellobiose
and cyclophellitol, which is unreactive, and secondarily a
mixture of 1 and glucose, which gives rise to the smaller observed
mass difference. The observed concentration-dependence
suggests that both hydrolytic processes have a higher KM than
the KI of the interaction between HiCel7B and 5. Thus, the
course of inhibition of HiCel7B with 5 is enzyme- and inhibitor
concentration-dependent, being affected by the KM of the two
possible hydrolytic pathways and the KI values for 5 and 1.
Scheme 1 Reagent and conditions: (a) TSMOTf, DCM,15 1C to 0 1C, 45%. (b) (i) NaOMe, MeOH. (ii) H2, Pd(OH)2/C, H2O, MeOH, dioxane, 40%. (c) (i) Tf2O, pyr,
DCM, 55 1C to rt. (ii) NaN3, DMF, 80 1C, 90%. (d) Ac2O, AcOH, H2SO4. (e) HSPh, BF3Et2O, DCM, 46% over 2 steps. (f) 2, Ph2SO, Tf2O, TTBP, DCM, 70 1C
to rt, 64%. (g) NaOMe, MeOH, DCM, 60%. (h) Na (s), t-BuOH, NH3, 60 1C, 53%. (i) 17, DIPEA, DMF, 27%; or 18, PFPOH, DIC, Et3N, DMF, 44%. (j) Cy5
alkyne, THPTA, CuI, DIPEA, DMSO, 46%. (k) (i) TFA, DCM; (ii) PFPOH, DIC, DMAP, DCM, 67%. (l) (i) PPh3, H2O, THF, 88%; (ii) BiotinNHS, DIPEA, DMF, 83%;
(iii) TFA, DCM, quant.
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To hopefully avoid the complication of internal hydrolysis, 13
was built on a b-1,4-glucosyl cyclophellitol inhibitor core.
Probe 13 turned out to be a strong inhibitor of HiCel7B,
reacting with a ki/KI of 2100 M
1 s1, comparable to that of the
5. Intact MS confirmed complete single labelling at a 5 : 2.2
probe : enzyme stoichiometric ratio (Fig. S4, ESI†), confirming
efficient labelling without hydrolysis. Modifying the azide
handle of 13 with Cy5 gave compound 14, which is an effective
probe for in-gel fluorescence-based detection of HiCel7B.
A serial dilution of HiCel7B with 14 gave significant signal
for the HiCel7B band from as little as 1.6 pg of enzyme per
well (Fig. S5, ESI†). Probe 14 also facilitated measurement of
the pH-labelling profile for HiCel7B (Fig. S6A, ESI†). Compar-
ison to the pH-activity profile for the hydrolysis of 4MU-GG
shows significant similarity between the pH-labelling profile
and pH-activity profile, particularly above pH 5 (Fig. S6B, ESI†).
The structure of the HiCel7B complex with inhibitor 1
Soaking HiCel7B crystals with 1 yielded the complex shown in
Fig. 2B. This confirmed that 1 binds in the expected manner,
mimicking the 4C1 conformation of two glucose units of cello-
biose previously observed in the 1 and 2 subsites (Fig. 2C).37
Binding of the inhibitor had no significant impact on the
structure of the active site, inducing no conformational change
following addition to the catalytic nucleophile. This is in spite of
the epoxide oxygen forming an extremely close (2.3 Å) contact
with the general acid/base. Extending beyond the 2 subsite, in
which essential hydrophobic stacking with W347 and hydrogen
bonding interactions with R108, Y147, and S345 are formed, the
active site broadens significantly, suggesting a lack of a specific
3 subsite, possibly accounting for the weak selectivity between
5 and 13.
Enzyme detection and identification by in-gel fluorescence and
biotin–avidin enrichment
To test the ability of the probe to stain b-D-glucanases in fungal
secretomes without staining b-D-glucosidases, an A. niger xylan-
grown secretome was stained with 14 or 19, followed by 19 or
Fig. 1 HiCel7B inhibition kinetics with inhibitor 1. (A) Plot of fluorescence
vs. time for HiCel7B in the presence of different concentrations of inhibitor
1. Each line represents a single measurement. (B) Plot of apparent decay
constant (kapp) extracted from an exponential decay fit of the curves
shown in panel A vs. inhibitor concentration with the hyperbolic fit shown
as a dotted line. Each point is the average of two measurements.
Fig. 2 Labelling of HiCel7B with 1. (A) Deconvoluted intact mass spectra of HiCel7B with (red) and without (black) incubation with 1. Dm (expected) =
338, Dm (observed) = 339. (B) Structure of the HiCel7B:1 complex showing 2Fo–Fc electron density at 2s. Amino acids having polar or hydrophobic
contacts with 1 are shown as purple sticks, 1, E197, and E202 are shown as tan sticks. (C) Overlay of 1 complex with Cellobiose:HiCel7B(E197S) complex
(PDB ID: 1OJK). Active site residues and cellobiose from PDB ID 1OJK are shown in green, active site residues and 1 from PDB ID 6YOZ (this work) are
shown in purple.
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14, respectively (Fig. 3A). 19-stained bands were present at
molecular weights of B45 kDa, B60 kDa, B100 kDa, and
B130 kDa. 14-stained bands were present at B35 kDa,
B40 kDa (faint), B60, and B80 kDa. Notably, the gel shows
minimal overlap between the staining of the two probes and
no apparent preclusion of staining of one probe by the other.
This suggests that among the retaining glycoside hydrolases
secreted by A. niger, there is no hydrolysis of 14 and no cross-
reactivity between 14 and 19. Thus, 4-O substitution appears to
reduce cross-reactivity with exo-glycosidases compared to the
previously reported xylanase probes.16
Based on the known content of this secretome, we tenta-
tively assigned the 60 and 80 kDa 14-stained bands as CbhA
and CbhB respectively, two GH7 cellulases.39 We also assigned
the B40 kDa band as EglB,40 a GH5 endo-b-D-glucanase, and
theB35 kDa band as XynC, an abundant GH10 xylanase likely
stained due to a loose enzyme-substrate specificity comparable
to other fungal GH10 xylanases.41,42 We tentatively assign the
100 and 130 kDa 19-stained bands as GH3 enzymes, possibly
BglA, BglM, and XlnD,38 which have been detected in this
secretome previously.16
To test the specificity of our cellulase probe architecture, we
used the biotinylated derivative (probe 15) and performed a
biotin–avidin pulldown enrichment prior to on-bead digestion,
peptide identification, and label-free quantification. Three samples
were prepared: a negative control, a probe 15-treated sample, and a
sample treated with probe 15 after treatment with inhibitor 1. The
only proteins from A. niger detected at elevated levels in the probe
15-treated samples relative to the negative control were CbhA,
CbhB, and XynC, confirming our assignment of the major
bands observed by in-gel fluorescence. Label-free quantifica-
tion showed a significant drop in CbhA and CbhB signal
following treatment with inhibitor 1, but revealed no signifi-
cant drop in XynC signal, suggesting that XynC was minimally
inhibited (Fig. 3B). Thus, the probe architecture presented here
shows specificity towards known GH7 cellulases within the
context of a complex fungal secretome.
Conclusions
b-1,4-Glucanases form the foundations of lignocellulose-degrading
systems. Being produced by a wide variety of saprotrophic,
symbiotic, and pathogenic microorganisms, the ability to
detect small quantities of these enzymes directly offers a variety
of opportunities for activity-based protein profiling. We have
shown here that a cellobiose-mimicking cyclophellitol deriva-
tive is a potent inhibitor of b-1,4-glucanases. We have also
shown that extension of this inhibitor from the 40 position with
glucose enhances inhibitor binding, but facilitates inhibitor
hydrolysis. Fortuitously, extension with a PEG linker enhances
binding without facilitating inhibitor hydrolysis. Furthermore,
the addition of a detection tag to the linker gives a potent and
selective activity-based probe which can be applied to the direct
detection of b-1,4-glucanases within a fungal secretome.
Data deposition
Coordinates and structure factors have been deposited with the
PDB, with accession codes 6OYZ (HiCel7B soaked with 1) and
6YP1 (HiCel7B Soaked with 13). Results from the label-free
quantitation proteomic experiment have been deposited in the
PRIDE database with the accession code PXD019930.
Author contributions
GJD and HO conceived the study. CB, EP, SPS, JJ, G van der M,
and JDCC performed or supervised organic synthesis. BIF
performed proteomics. JR, AFJR and GPvanW prepared Aspergillus
Fig. 3 (A) Staining of the A. niger xylan-grown secretome with 14 and 19.
Dual channel fluorescence scan of a 4–20% SDS-PAGE is shown. Lane 1
contains 14-stained secretome, lane 2 contains 14-stained secretome
subsequently stained with 19, lane 3 contained 19-stained secretome, and
lane 4 contains 19-stained secretome subsequently stained with 14.
(B) Label-free quantification of proteins identified from the A. niger
secretome following treatment with probe 15 and biotin–avidin enrich-
ment. The ‘‘No Probe’’ sample is the negative control, the ‘‘Competition’’
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